cell-free DNA
Oncocyte Nets $10.2M in Private Placement, Notes New Customers for Transplant Test
The company intends to use the funds for general corporate purposes as it seeks to gain customers and regulatory support for its GraftAssure transplant rejection test.
Liquid Biopsy Startup Aitiologic Launches With €2.5M in Private-Public Funding
The company said it is commercializing a cell-free DNA assay based on a proprietary technology developed by a company cofounder at Siemens Healthineers.
Qiagen Sues Zymo Research Over Cell-Free Nucleic Acid Sample Prep IP
Last month, Qiagen filed a patent infringement lawsuit, alleging that Zymo Research infringes its US patents No. 10,184,145 and No. 11,021,736.
The San Jose, California-based company has developed AccuScan, which analyzes a patient's circulating tumor DNA but does not require bespoke reagents.
BillionToOne Inks $140M Financing Agreement With Oberland Capital
The company said the funds will help it shore up its plans to reach profitability and supplant the need for additional financing rounds.